Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-07-06

Clinical Trial Update: Growth Hormone as Add-on Treatment in Severe Fibromyalgia With Low IGF-1 Serum Levels (56 Characters) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated growth hormone as add-on therapy in adults with severe fibromyalgia and low IGF-1, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Growth Hormone (somatropin)

Snippet

Sponsor: Centro Medico Teknon | Conditions: Fibromyalgia, Growth Hormone Deficiency | Phase 2 | Status: COMPLETED